178 related articles for article (PubMed ID: 20965723)
1. Biarylimidazoles as inhibitors of microsomal prostaglandin E2 synthase-1.
Wu TY; Juteau H; Ducharme Y; Friesen RW; Guiral S; Dufresne L; Poirier H; Salem M; Riendeau D; Mancini J; Brideau C
Bioorg Med Chem Lett; 2010 Dec; 20(23):6978-82. PubMed ID: 20965723
[TBL] [Abstract][Full Text] [Related]
2. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation.
Xu D; Rowland SE; Clark P; Giroux A; Côté B; Guiral S; Salem M; Ducharme Y; Friesen RW; Méthot N; Mancini J; Audoly L; Riendeau D
J Pharmacol Exp Ther; 2008 Sep; 326(3):754-63. PubMed ID: 18524979
[TBL] [Abstract][Full Text] [Related]
3. Pharmacophore modeling and virtual screening for novel acidic inhibitors of microsomal prostaglandin E₂ synthase-1 (mPGES-1).
Waltenberger B; Wiechmann K; Bauer J; Markt P; Noha SM; Wolber G; Rollinger JM; Werz O; Schuster D; Stuppner H
J Med Chem; 2011 May; 54(9):3163-74. PubMed ID: 21466167
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel mPGES-1 inhibitors through screening of a chemical library.
Park SJ; Han SG; Ahsan HM; Lee K; Lee JY; Shin JS; Lee KT; Kang NS; Yu YG
Bioorg Med Chem Lett; 2012 Dec; 22(24):7335-9. PubMed ID: 23147075
[TBL] [Abstract][Full Text] [Related]
5. Structure-based discovery of inhibitors of microsomal prostaglandin E2 synthase-1, 5-lipoxygenase and 5-lipoxygenase-activating protein: promising hits for the development of new anti-inflammatory agents.
De Simone R; Chini MG; Bruno I; Riccio R; Mueller D; Werz O; Bifulco G
J Med Chem; 2011 Mar; 54(6):1565-75. PubMed ID: 21323313
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886.
Riendeau D; Aspiotis R; Ethier D; Gareau Y; Grimm EL; Guay J; Guiral S; Juteau H; Mancini JA; Méthot N; Rubin J; Friesen RW
Bioorg Med Chem Lett; 2005 Jul; 15(14):3352-5. PubMed ID: 15953724
[TBL] [Abstract][Full Text] [Related]
7. Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E2.
Sampey AV; Monrad S; Crofford LJ
Arthritis Res Ther; 2005; 7(3):114-7. PubMed ID: 15899061
[TBL] [Abstract][Full Text] [Related]
8. Microglia-specific expression of microsomal prostaglandin E2 synthase-1 contributes to lipopolysaccharide-induced prostaglandin E2 production.
Ikeda-Matsuo Y; Ikegaya Y; Matsuki N; Uematsu S; Akira S; Sasaki Y
J Neurochem; 2005 Sep; 94(6):1546-58. PubMed ID: 16000148
[TBL] [Abstract][Full Text] [Related]
9. Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics.
Luz JG; Antonysamy S; Kuklish SL; Condon B; Lee MR; Allison D; Yu XP; Chandrasekhar S; Backer R; Zhang A; Russell M; Chang SS; Harvey A; Sloan AV; Fisher MJ
J Med Chem; 2015 Jun; 58(11):4727-37. PubMed ID: 25961169
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological evaluation of a selected library of new potential anti-inflammatory agents bearing the gamma-hydroxybutenolide scaffold: a new class of inhibitors of prostanoid production through the selective modulation of microsomal prostaglandin E synthase-1 expression.
Guerrero MD; Aquino M; Bruno I; Terencio MC; Paya M; Riccio R; Gomez-Paloma L
J Med Chem; 2007 May; 50(9):2176-84. PubMed ID: 17407277
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E2 synthesis in vitro and ameliorates experimental periodontitis in vivo.
Kats A; Båge T; Georgsson P; Jönsson J; Quezada HC; Gustafsson A; Jansson L; Lindberg C; Näsström K; Yucel-Lindberg T
FASEB J; 2013 Jun; 27(6):2328-41. PubMed ID: 23447581
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 produced by microsomal prostaglandin E synthase-1 regulates the onset and the maintenance of wakefulness.
Takemiya T
Neurochem Int; 2011 Nov; 59(6):922-4. PubMed ID: 21784115
[TBL] [Abstract][Full Text] [Related]
13. Identification and Characterization of Novel Microsomal Prostaglandin E Synthase-1 Inhibitors for Analgesia.
Chandrasekhar S; Harvey AK; Yu XP; Chambers MG; Oskins JL; Lin C; Seng TW; Thibodeaux SJ; Norman BH; Hughes NE; Schiffler MA; Fisher MJ
J Pharmacol Exp Ther; 2016 Mar; 356(3):635-44. PubMed ID: 26740668
[TBL] [Abstract][Full Text] [Related]
14. Identification of furo[3', 2':3,4]naphtho[1,2-d]imidazole derivatives as orally active and selective inhibitors of microsomal prostaglandin E(2) synthase-1 (mPGES-1).
Tseng CH; Tzeng CC; Shih PK; Yang CN; Chuang YC; Peng SI; Lin CS; Wang JP; Cheng CM; Chen YL
Mol Divers; 2012 May; 16(2):215-29. PubMed ID: 22161217
[TBL] [Abstract][Full Text] [Related]
15. Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1.
Koeberle A; Siemoneit U; Bühring U; Northoff H; Laufer S; Albrecht W; Werz O
J Pharmacol Exp Ther; 2008 Sep; 326(3):975-82. PubMed ID: 18550688
[TBL] [Abstract][Full Text] [Related]
16. Nonacidic inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1) identified by a multistep virtual screening protocol.
Rörsch F; Wobst I; Zettl H; Schubert-Zsilavecz M; Grösch S; Geisslinger G; Schneider G; Proschak E
J Med Chem; 2010 Jan; 53(2):911-5. PubMed ID: 20025212
[TBL] [Abstract][Full Text] [Related]
17. Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin.
Schaible AM; Traber H; Temml V; Noha SM; Filosa R; Peduto A; Weinigel C; Barz D; Schuster D; Werz O
Biochem Pharmacol; 2013 Aug; 86(4):476-86. PubMed ID: 23623753
[TBL] [Abstract][Full Text] [Related]
18. Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro.
Bruno A; Di Francesco L; Coletta I; Mangano G; Alisi MA; Polenzani L; Milanese C; Anzellotti P; Ricciotti E; Dovizio M; Di Francesco A; Tacconelli S; Capone ML; Patrignani P
Biochem Pharmacol; 2010 Apr; 79(7):974-81. PubMed ID: 19925781
[TBL] [Abstract][Full Text] [Related]
19. The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.
Koeberle A; Rossi A; Zettl H; Pergola C; Dehm F; Bauer J; Greiner C; Reckel S; Hoernig C; Northoff H; Bernhard F; Dötsch V; Sautebin L; Schubert-Zsilavecz M; Werz O
J Pharmacol Exp Ther; 2010 Mar; 332(3):840-8. PubMed ID: 19934399
[TBL] [Abstract][Full Text] [Related]
20. Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor.
Mbalaviele G; Pauley AM; Shaffer AF; Zweifel BS; Mathialagan S; Mnich SJ; Nemirovskiy OV; Carter J; Gierse JK; Wang JL; Vazquez ML; Moore WM; Masferrer JL
Biochem Pharmacol; 2010 May; 79(10):1445-54. PubMed ID: 20067770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
